Data residency in the Gulf: what technology leaders should plan for
The question has moved from where data sits to who can reach it, and under which law. Four decisions to make this year, and the questions to put to every supplier.
Section
Architecture, security, data and AI as they look from the top table: what to fund, what to stop, and what to ask the people who build it.

The question has moved from where data sits to who can reach it, and under which law. Four decisions to make this year, and the questions to put to every supplier.
DORA and NIS2 have moved supplier risk out of the procurement appendix and into the board pack. What has changed in the contracts, and the three clauses worth asking about this quarter.
Okba Chabbi launched AIUNIVERS in 2024 on a simple premise: AI is neither moral nor immoral, the intent behind it is. Its founder on building partnerships from Luxembourg to South Korea.
From regional vice president at Tech Mahindra and division president at Amdocs to chief executive roles of his own, Loukas Tzitzis on the different rhythms of startups and large enterprises, and why people are the multiplier.
Big companies have always had seasoned technology leaders steering their strategy. Jeff Roberts founded Innovation Vista so that small and midsize firms could have one too.
Part-time senior technology leadership has become a serious option for growing companies. What it can do, what it cannot, and the signs that the business has outgrown it.
Camera-based inspection needs answers in milliseconds, not round trips to a distant cloud region. The architecture manufacturers are settling on, and the operational problems nobody budgets for.
The chief executive of Global Procurement Group on ClearVUE, its energy management business in the Gulf, and what procurement discipline does for a company's energy bill.
The founder of the Artificial Intelligence Defense Platform on ISABELLA, the system at its heart, and on using AI to protect communities rather than simply to sell to them.
From process chemistry at JK Industries to drug discovery at Wockhardt, Dr Madhuresh Kumar Sethi on the discipline that takes a molecule through US and European regulatory approval.